Expecting a CE Mark for BloodChip, Progenika Will Grow US Presence and Submit Dx to FDA | GenomeWeb
Progenika, a Spanish biotech firm that has developed a series of array-based diagnostics, is moving forward with plans to market a chip for blood typing in Europe while at the same time positioning itself to pursue US Food and Drug Administration clearance for several of its products, including BloodChip, according to a company spokesperson.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.